Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: 10.1007/s13300-021-01179-8

Event: Veröffentlichung

(where): Aachen

(who): Universitätsbibliothek der RWTH Aachen

(when): 2021

Creator: Gourdy, Pierre
Bonadonna, Riccardo C.
Freemantle, Nick
Mauricio, Didac
Müller-Wieland, Dirk
Bigot, Gregory
Mauquoi, Celine
Ciocca, Alice
Bonnemaire, Mireille

DOI: 10.18154/RWTH-CONV-248329

URN: urn:nbn:de:101:1-2023020100330484895034

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gourdy, Pierre
Bonadonna, Riccardo C.
Freemantle, Nick
Mauricio, Didac
Müller-Wieland, Dirk
Bigot, Gregory
Mauquoi, Celine
Ciocca, Alice
Bonnemaire, Mireille
Universitätsbibliothek der RWTH Aachen

Time of origin

2021

Other Objects (12)

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis

Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis

iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data

Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis

Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis

iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data

Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis

Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis

iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data

Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis

Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis

iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data

Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis

Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis

iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data

Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis

Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis

Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis

Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis

iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data

Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis

Related objects

Reset password